IGF1 and breast carcinoma: It has been demonstrated that the hyperactivation of Insulin/IGF-1 pathway due to “diabesity” condition (obesity concomitant with insulin resistance, hyperinsulinemia and/or hyperglycemia) mediates breast cancer progression (37–39).